Tissue Engineered Skin Substitutes Market to Cross $845 Million by 2025 - Global Industry Insights and Opportunities

Dublin, IRELAND


Dublin, March 12, 2021 (GLOBE NEWSWIRE) -- The "Global Tissue Engineered Skin Substitutes Market (2020-2025) by Biomaterial, Anatomical Structure, Product Type, Application, Technology, Duration, End-user, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

The Global Tissue Engineered Skin Substitutes Market is estimated to be USD 695 million in 2020 and is expected to reach USD 845.6 million by 2025, growing at a CAGR of 4%.

Market Dynamics

Key factors, such as increasing prevalence of acute and chronic wounds, growing burn & trauma cases, rising demand for skin grafts, and rising focus on technological advancements have led to a rise in tissue engineered skin substitutes market.

Increase in number of patients suffering from diabetic and vascular ulcers is also driving the need for tissue engineering. Rising awareness regarding various treatment options, ability of tissue engineering to replace conventional auto- and allografts is also fuelling the demand for tissue engineered skin substitutes.

However, the factor such as lack of proper reimbursement policies, high treatment cost and prolonged duration required for treatment is hindering the market growth. Issues with biomaterials used for skin grafts, such as biomaterial-centred infection and poor tissue integration may be challenging for the growth of the market.

Market Segmentation

The Global Tissue Engineered Skin Substitutes Market is segmented further based on Biomaterial, Anatomical Structure, Product Type, Application, Technology, Duration, End-user, and Geography.

  • By Biomaterial, the market is classified as autologous, allogeneic, xenogeneic and amnion. Amongst the two, the Autologous segment is estimated to hold the highest market share.
  • By Anatomical Structure, the market is segmented as Cellular and Acellular. Acellular Anatomical Structure is estimated to hold the highest market share during the forecast period.
  • By Product Type, the market is classified as Natural and Synthetic. Synthetic products are further segmented as biodegradable and Non-biodegradable. Natural segment holds the highest market share.
  • By Application, the market is classified as chronic wounds, burns cases, traumatic wounds, diabetic foot ulcers and others. Amongst all, the Chronic Wounds segment is estimated to hold the highest market share.
  • By Technology, the market is classified as Laser assisted bio-printing, 3D, Robotic Technology, and Others. Amongst them, the 3D Technology is estimated to hold the highest market share.
  • By Duration, the market is classified as Permanent and Semi-permanent. Amongst the two, the Permanent segment is estimated to hold the highest market share.
  • By End-user, the market is classified as Hospital and Clinic, Ambulatory Surgical Center, and Others. The Hospital and Clinic segment is estimated to hold the highest market share.
  • By Geography, North America dominates the market.

Recent Developments

  • Acelity enters agreement to transition Systagenix manufacturing facility to Scapa Healthcare - September 2020
  • Integra LifeSciences Announces Definitive Agreement to Acquire ACell, Inc. - December 2020

Company Profiles

Some of the companies covered in this report Smith & Nephew, Molnlycke Health Care, Integra LifeSciences, Regenicin., Organogenesis Inc, MiMedx., LifeNet Health, Kerecis, Medline Industries, BSN medical, ConvaTec Group, Mallinckrodt, Tissue Regenix, etc.

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments and growth in market share.

Report Highlights

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

Key Topics Covered

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Shareholders

2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.3 Market Size Estimation
2.4 Assumptions of the Study
2.5 Limitations of the Study

3 Executive Summary

4 Market Overview
4.1 Introduction
4.2 Market Dynamics
4.2.1 Drivers
4.2.1.1 Increasing Prevalence of Acute and Chronic Wounds
4.2.1.2 Rising Demand for Skin Grafts
4.2.1.3 Rising Awareness Regarding Various Treatment Options
4.2.1.4 Increasing Adoption and a Suitable Alternative to Auto-And Allografts
4.2.1.5 Rising Incidences of Accidents, Such as Road Accidents, Burns, and Trauma
4.2.2 Restraints
4.2.2.1 Lack of Proper Reimbursement Policies
4.2.2.2 High Cost of Treatment and Prolonged Treatment Time
4.2.2.3 Inability of Biologists, Biochemists, and Technical Engineers to Reproduce Skin Appendages
4.2.3 Opportunities
4.2.3.1 Focus of Researchers on Establishing New Construction Technologies in the Arena of Skin Tissue Engineering
4.2.4 Challenges
4.2.4.1 Difficulty in Producing Complex Skin Substitutes That Can Readily Be Transplanted in Large Quantities
4.2.4.2 Issues With the Biomaterials Used for Skin Grafts
4.2.4.3 Challenges in Finding a Substitute for Split-Thickness Grafts
4.3 Trends
4.3.1 The 3-D bio textile and bio printing

5 Market Analysis
5.1 Porter's Five Forces Analysis
5.2 Impact of COVID-19
5.3 Ansoff Matrix Analysis

6 Global Tissue Engineered Skin Substitutes Market, By Biomaterial
6.1 Introduction
6.2 Autologous
6.3 Allogeneic
6.4 Xenogeneic
6.5 Amnion

7 Global Tissue Engineered Skin Substitutes Market, By Anatomical Structure
7.1 Introduction
7.2 Cellular
7.3 Acellular

8 Global Tissue Engineered Skin Substitutes Market, By Product Type
8.1 Introduction
8.2 Natural
8.3 Synthetic
8.3.1 Biodegradable
8.3.2 Non-Biodegradable

9 Global Tissue Engineered Skin Substitutes Market, By Application
9.1 Introduction
9.2 Chronic Wounds
9.3 Burns Cases
9.4 Traumatic Wounds
9.5 Diabetic Foot Ulcers
9.6 Others

10 Global Tissue Engineered Skin Substitutes Market, By Technology
10.1 Introduction
10.2 Laser assisted bio-printing
10.3 3D
10.4 Robotic Technology
10.5 Others

11 Global Tissue Engineered Skin Substitutes Market, By Duration
11.1 Introduction
11.2 Permanent
11.3 Semi-permanent

12 Global Tissue Engineered Skin Substitutes Market, By End-user
12.1 Introduction
12.2 Hospital and Clinic
12.3 Ambulatory Surgical Centre
12.4 Others

13 Global Tissue Engineered Skin Substitutes Market, By Geography
13.1 Introduction
13.2 North America
13.3 South America
13.4 Europe
13.5 Asia-Pacific
13.6 Rest of the World

14 Competitive Landscape
14.1 IGR Competitive Quadrant
14.2 Market Share Analysis
14.3 Competitive Scenario
14.3.1 Mergers & Acquisitions
14.3.2 Agreement, Collaborations, & Partnerships
14.3.3 New Product Launches & Enhancements
14.3.4 Investments & funding

15 Company Profiles
15.1 Organogenesis, Inc.
15.2 Smith & Nephew
15.3 BSN Medical
15.4 Molnlycke Health Care
15.5 Integra LifeSciences
15.6 Medtronic
15.7 Tissue Regenix Ltd.
15.8 Stratatech (A Mallinckrodt Company)
15.9 Regenicin
15.10 MiMedx
15.11 LifeNet Health
15.12 Kerecis
15.13 Medline Industries, Inc.
15.14 ConvaTec Group
15.15 Mallinckrodt
15.16 Amarantus Bioscience Holdings
15.17 3M Inc.

For more information about this report visit https://www.researchandmarkets.com/r/vn0mls

 

Contact Data